このエントリーをはてなブックマークに追加
ID 15141
Eprint ID
15141
FullText URL
Thumnail 121_119.pdf 355 KB
Title Alternative
Antibody medicine
Author
Note
Keyword
Published Date
2009-08-03
Publication Title
岡山医学会雑誌
Publication Title Alternative
Journal of Okayama Medical Association
Volume
volume121
Issue
issue2
Publisher
岡山医学会
Publisher Alternative
Okayama Medical Association
Start Page
119
End Page
122
ISSN
0030-1558
NCID
AN00032489
Content Type
Journal Article
Related Url
http://www.okayama-u.ac.jp/user/oma/index.html
References
1) Köhler G, Milstein C : Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 256, 495-497.
2) Okada Y, Tadokoro J : The distribution of cell fusion capacity among several cell strains or cells caused by HVJ. Exp Cell Res (1963) 32, 417-430.
3) Morrison SL, Johnson MJ, Herzenberg LA, Oi VT : Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A (1984) 81, 6851-6855.
4) Roguska MA, Pedersen JT, Keddy CA, Henry AH, Searle SJ, Lambert JM, Goldmacher VS, Blättler WA, Rees AR, Guild BC : Humanization of murine monoclonal antibodies through variable domain resurfacing. Proc Natl Acad Sci U S A (1994) 91, 969-973.
5) Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR : Making antibodies by phage display technology. Annu Rev Immunol (1994) 12, 433-455.
6) Tomizuka K, Yoshida H, Uejima H, Kugoh H, Sato K, Ohguma A, Hayasaka M, Hanaoka K, Oshimura M, Ishida I : Functional expression and germline transmission of a human chromosome fragment in chimaeric mice. Nat Genet (1997) 16, 133-143.
7) 石田 功 : ヒト抗体作製の最新技術. 実験医学(2002)20, 846-851.
8) Shields RL, Lai J, Keck R, O' Connell LY, Hong K, Meng YG, Weikert SH, Presta LG : Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem (2002) 277, 26733-26740.
9) Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, Hanai N, Shitara K : The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem (2003) 278, 3466-3473.
10) Feldmann M, Maini SR : Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev (2008) 223, 7-19.
11) Nishimoto N, Kishimoto T : Humanized antihuman IL-6 receptor antibody, tocilizumab. Handb Exp Pharmacol (2008) 181, 151-160.
12) Shepard HM, Lewis GD, Sarup JC, Fendly BM, Maneval D, Mordenti J, Figari I, Kotts CE, Palladino MA Jr, Ullrich A, Slamon D : Monoclonal antibody therapy of human cancer : taking the HER2 protooncogene to the clinic. J Clin Immunol (1991) 11, 117-127.
13) Boye J, Elter T, Engert A : An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol (2003) 14, 520-535.
14) Ferrara N, Hillan KJ, Novotny W : Bevacizumab (Avastin), a humanized
122
anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun (2005) 333, 328-335.
15) Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, Kanke T, Sato Y, Hiraga N, Adachi N, Yoshino T, Nishibori M : Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J (2007) 21, 3904-3916.
language
日本語
Copyright Holders
岡山医学会
File Version
publisher
Refereed
True
DOI
Eprints Journal Name
joma